Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The Applications of AI in life science

Artificial Intelligence is having a big impact on the life science sector. Diagnosing and treating patients is becoming more effective thanks to AI, and pharma companies are relying on the up-and-coming technology to speed up their drug discovery projects. In this second article in BioStock’s article series on AI, we take a closer look at the general impact of AI in life science.  Read the full article at BioStock.se: https://www.biostock.se/2020/05/the-applications-of-ai-in-life-science/

Presentation of Polygon first quarter 2020 report

On Tuesday May 5, 2020 at 08.00 CET, Polygon AB (publ) will publish its first quarter 2020 report.Financial analysts and investors in Polygon senior secured notes are invited to participate in a telephone conference on the same day at 11:00 CET where the Q1 report will be presented. The event will be hosted by Polygon´s CEO Axel Gränitz and CFO Martin Hamner. The presentation will be held in English. Slides for the presentation will be made available on our website https://www.polygongroup.com/investors/financial-reports/ prior to the start of the conference. To participate in the

ExpreS2ion announces supporting an advantageous COVID-19 diagnostic antibody development project

Hørsholm, Denmark, May 4, 2020 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, announces that its SARS-CoV-2 antigen is being applied across multiple research and development projects, including an on-going diagnostic antibody test program that Rigshospitalet, University of Copenhagen and Novo Nordisk jointly develop to support the diagnosis of COVID-19 in Denmark on a national level.ExpreS[2]ion and its joint venture partner AdaptVac are engaged in the development of a unique capsid virus-like particle (VLP) COVID-19

UPM-Kymmene Corporation: Managers’ Transactions (Oudeman)

UPM-Kymmene Corporation       Stock Exchange Release (Managers' Transactions) 4 May 2020 at 09:45 EET UPM-Kymmene Corporation: Managers’ Transactions (Oudeman) UPM-Kymmene Corporation has on 30 April 2020 received the following notification:  Person subject to the notification requirementName: Oudeman, MarjanPosition: Member of the BoardIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64 Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2020-04-30Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHARE

Reminder: C-RAD Web Presentation Interim Report Q1 2020

Presentation of the interim report for the first quarter of the fiscal year 2020: Date: Wednesday May 6, 2020 / kl. 11:00 CET Venue: Online Presentation Topic: C-RAD Web Presentation Interim Report Q1 2020 Procedure: Please register online through the website:   https://attendee.gotowebinar.com/register/5849606775349311504 After your registration, you will receive a confirmation via email. A recording of the presentation will be made accessible on the C-RAD website after the presentation. About C-RAD C-RAD develops innovative solutions for use in advanced

Cantargia IND application for CAN04 approved by FDA

Cantargia AB today announced that the IND application regarding the antibody CAN04 has been approved by the US FDA. CAN04, an antibody targeting interleukin 1 receptor accessory protein (IL1RAP), is currently being investigated for treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer (PDAC) in phase IIa clinical development. CAN04 development can now be expanded to the US with a new phase Ib clinical trial investigating CAN04 in combination with immunotherapy in selected cancer forms overexpressing IL1RAP.Cantargia develops antibody-based pharmaceuticals against IL1RAP. The

Interim Report Q1 - January – March, 2020 Redsense Medical AB (publ)

FINANCIAL SUMMARY First quarter, 1 Januari – 31 Mars 2020 The Group · Net sales amounted to kSEK 4,996 (1,964), a 154 percent increase compared with the corresponding period in 2019. · Earnings before tax amounted to kSEK 241 (-706). · Total equity amounted to kSEK 14,947 at the end of the period. · Available liquid assets amounted to kSEK 9,778 at the end of the period. The Parent Company · Net sales amounted to kSEK 3,795 (1,406). · Earnings before tax amounted to kSEK 26 (-349). · Total equity amounted to kSEK 56,787 at the end of the period. ·

Christian Luiga leaves Telia Company

Christian Luiga, Chief Financial Officer and previously acting CEO and President, has today submitted his resignation and informed the Board of Telia Company and the new CEO and President Allison Kirkby that he will leave Telia Company.Christian Luiga has been working for Telia Company in various positions since 2009 and started as CFO in April 2014. Since September 2019, he has been the acting CEO and President. Christian Luiga will be at the company’s disposal during his notice period to support the new CEO Allison Kirkby and assist with the hand-over of several ongoing projects. During

PHI secure working capital until 2022

To bridge and adapt to the consequences of the COVID-19 pandemic, Phase Holographic Imaging (PHI) has received a binding credit facility of 15 MSEK. Together with the furloughing covenant that was recently concluded with the labor union Sveriges Ingenjörer, the company anticipates that the credit facility will secure the company's working capital until 2022. The facility provides PHI with a reserve in case additional aid provided by the government proves to be too compromised and insufficient, once it reaches companies in its final form.Closed borders, travel restrictions and customers in

Veidekke ASA: Appoints sustainability director

Catharina Bjerke has been appointed Veidekke’s new sustainability director, with responsibility for strategic development of the group’s sustainability work. Up until now, Bjerke served as EVP in Veidekke ASA and CEO of Veidekke Industrial.Sustainability is high on the agenda in Veidekke. The company has set ambitious climate targets and is working purposefully to find sustainable solutions for the construction and civil engineering industry. Examples are low-temperature asphalt, where the company is Norway’s largest, fossil-free construction sites, including the world's first fossil-free

Invitation to webcasted conference – Q1 2020

BEWiSynbra’s interim report for the first quarter 2020 will be published on Friday 15 May at around 08.00 CET. BEWiSynbra’s CEO Jonas Siljeskär and CFO Marie Danielsson will present the interim report via a webcasted conference on the same day at 11.00 CET. The presentation will be held in English and will be followed by a Q&A session. To participate via webcast and thereby be able to ask questions, please register in advance: https://us02web.zoom.us/webinar/register/WN_TOAjnBmMT725qzne-RUujgWelcome!

Redeye: Beijer Electronics Group - Solid Post-Pandemic Rebound Expected

Redeye leaves estimates and valuation unchanged, following mostly in-line Q1’20 performance, and reiterate our positive long-term stance on the stock. More importantly, the company’s communication in the report and conference call makes us even more confident that it will be able to sustain a potential period of lower activity and succeed in a solid post-pandemic rebound. Base case amounts to SEK 46 per share. Read more and download the initial research report: https://bit.ly/2z5J1aU  Start following companies at Redeye to receive the latest equity research within Life Science and

Steps in the Arctic circular economy – renewable Finnish biogas from biowaste from Rovaniemi, Ranua and Pello

In future, biowaste from residents in Rovaniemi, Ranua and Pello will be turned into renewable Finnish biogas and recycled nutrients at Gasum’s biogas plant in Oulu. A contract between energy company Gasum and municipal waste management company Napapiirin Residuum Oy marks a new step in the regional circular economy in Northern Finland. In future, residents’ biowaste will be recycled into a fuel for the tanks of gas vehicles."Municipalities and municipal waste management companies have an important role in promoting the production of Finnish biogas and transport emission reductions. At the

Archer Limited: Archer supports the planned merger between Quintana Energy Services Inc. and KLX Energy Services Holdings Inc.

Hamilton Bermuda (May 4, 2020) Reference is made to the announcement on May 3, 2020, by Quintana Energy Services Inc. (“QES”), whereby QES outlined its plan to merge with the Nasdaq listed U.S. onshore oilfield services company KLX Energy Services Holdings Inc. (“KLXE”) in an all-stock transaction (the “Transaction”). KLXE and QES plan to combine their services, establishing an industry-leading provider of asset-light oilfield solutions across the full well lifecycle including drilling, completing and production related products and services. Archer currently owns approximately 28.1%

Apetit Plc: Notice to the Annual General Meeting

Apetit Plc, Stock Exchange Release, 4 May 2020 at 09:00 a.m.Shareholders of Apetit Plc (“Apetit” or “the company”) are invited to the Annual General Meeting, which will be held on Tuesday, 26 May 2020 at 2:00 p.m. at the company’s head office at Maakunnantie 4, Säkylä, Finland. Measures due to coronavirus Apetit takes the coronavirus situation very seriously and seeks to secure the interests of the company and its shareholders by holding an Annual General Meeting on 26 May 2020. This also allows for a decision on the payment of a dividend proposed by the Board. The company takes a

Herantis Pharma publishes newsletter for March-April

Herantis Pharma PlcPress release 4 May 2020 at 9:00 am Eastern European Time Herantis Pharma Plc (“Herantis”) has published its newsletter for March-April 2020. The newsletter is also attached to this press release. Herantis’ newsletter is published every other month on the company’s web site . It is also available by email subscription . Further information: Herantis Pharma plc, Pekka Simula, CEO, telephone: +358 40 7300 445Company web site: www.herantis.com About Herantis Pharma Plc

Invitation to the presentation of Recipharm’s interim report January - March 2020

Recipharm AB will publish its interim report for January - March 2020 on 7[th] May at 07:45 am CET. The company invites investors, analysts and media to a web conference (in English) on 7[th] May at 10:00 am CET, where CEO Thomas Eldered and CFO Tobias Hägglöv will present and comment on the report as well as answer questions. The report will be available on Recipharm’s website www.recipharm.com/investor-relations from 7:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 7[th] May. Click here 

Castellum begins construction on Malmö’s new Swedish National Courts building – invests 1.3 billion kronor

Castellum is starting construction of Malmö’s new Swedish National Courts Administration building in the expanding Nyhamnen district of central Malmö. The area will become one of northern Europe’s largest workplaces for legal practitioners. Building permit has now been issued and construction start is planned for second quarter, 2020.When the building is completed, it will comprise approx. 26,500 square meters of modern premises, of which approx. 24,000 sq.m. will be leased by the Swedish National Courts Administration and house the Malmö District Court and the Administrative Court, as well

New test results from Corcel Project confirm high proportion of nickel sulphide

Eurobattery Minerals AB (Nordic Growth Market: “BAT”; “the Company”), a growth company in the mining and exploration industry with the vision to help Europe become self-sufficient in ethical battery minerals, today announce the preliminary results for sulphide mineral tests at the nickel, cobalt, copper Castriz prospect in Galicia, northern Spain. In the larger Corcel project, Castriz is one of three primary prospect areas together with Monte Mayor and Monte Castello. Key points: · Preliminary results received from nickel sulphide mineral tests on mineralised samples from recent

Nanoform awarded GMP certification

Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, has been awarded a Good Manufacturing Practices (GMP) certification by the Finnish Medicines Agency, FIMEA. Achieving GMP status permits Nanoform to manufacture an investigational drug, developed using its proprietaryCESS[® ]nanoparticle engineering platform, for use in clinical trials. The GMP certification represents a very important milestone for Nanoform as it continues to increase the commercial reach of its CESS[®] technology, which reduces the size of API particles to

Update to DreamHack’s 2020 esports schedule for festivals and Master properties

STOCKHOLM, May 4[th] 2020 — Modern Times Group MTG AB’s (MTG) portfolio company DreamHack has announced further changes to its 2020 festival and Master properties schedule, adjusted for impacts from the ongoing Coronavirus pandemic.MTG’s portfolio company DreamHack has decided to adjust additional events in its esports Master properties and festival schedule to ensure business continuity and continued delivery of esports entertainment in a responsible way, while taking into account current limitations and restrictions on a country per country basis to stop the novel Coronavirus pandemic.

Nel ASA: Invitation to presentation of Q1 2020 results

(Oslo, 4 May 2020) Nel ASA (Nel) will announce the first quarter 2020 report on Thursday 7 May at 07:00 CET and will host an open on-line presentation at 08:00 CET. Due to the extraordinary situation with Covid-19, and considering prevailing meeting recommendations and restrictions, the Q1 2020 results presentation will not be held as a physical meeting. The presentation will be broadcasted live at www.nelhydrogen.com and can also streamed at https://channel.royalcast.com/webcast/hegnarmedia/20200507_4/. The presenter will be Jon André Løkke, CEO, and the presentation will be held in

Haldex recruits Lottie Saks as new CFO

Haldex has recruited Lottie Saks as new CFO. She succeeds Andreas Larsson, who ends on 30 July 2020. Lottie will take up the position as CFO on 1 June 2020.Lottie Saks has extensive experience from leading finance roles in companies with significant international operations. Lottie most recently came from the role as CFO at Cint. Prior to that, she worked for five years as CFO of OneMed, a European provider of healthcare products owned by listed venture capital firm 3i. She previously held senior positions at, among others, OMX Technology Financial Markets and Johnson & Johnson. She began

There are no items matching the current filter
There are no more items matching the current filter
Back to top